Bullish Case: Known: STLA’s term structure is still backwardated, but IV drifts down with duration (roughly ~65–70% near Aug ’26 toward ~50–55% later ’26/’27), and call flow exceeds put flow. Inferred: fear is concentrated in far OTM puts (vol-surface spikes), so mean reversion can lift price if near-term catalysts don’t deteriorate. Recent US sales momentum (+5% H1, June +10%) supports stabilization. Previous -33%/90d downside partially played out.

Bearish Case: Known: STLA vol surface is sharply put-skewed, with very high IV clustered at low strikes (~3–4) suggesting priced gap risk; SPY’s surface is far flatter (~10–20% IV), so this is stock-specific. Inferred: left-tail mass in the historical return surface + backwardation implies negative drift until fear compresses. Some prior “>20% downside” weight likely got used (-33%/90d), but if low-strike put IV stays elevated into late July/early Aug, more downside remains plausible.

Potential Outcomes:

1. 25%: -20%+ by Aug earnings if low-strike put IV stays >~60 and guidance/recall/labor headlines miss.
2. 40%: -10%..+10% range if IV term structure keeps rolling down and no new incident emerges.
3. 20%: +15%..+30% if puts compress toward ~50–55 and US sales/FCF trends improve.
4. 10%: M&A/strategic premium if credible bidder chatter surfaces by Jul 2027.
5. 5%: distress tail if liquidity/covenant concerns intensify and IV skew widens.

July 22, 2026